These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8345050)
21. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test. Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331 [TBL] [Abstract][Full Text] [Related]
22. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade. Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252 [TBL] [Abstract][Full Text] [Related]
23. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma. Nelson RL; Service FJ; Go VL Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728 [TBL] [Abstract][Full Text] [Related]
24. Concurrent insulinoma and impaired glucose tolerance suspected as owing to obesity. Iizuka K; Fujisawa T; Takeda J BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26729835 [TBL] [Abstract][Full Text] [Related]
25. Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties. Wiesli P; Schmid C; Perren A; Pfammatter T; Spinas GA; Keller U J Endocrinol Invest; 2004 Oct; 27(9):832-8. PubMed ID: 15648547 [TBL] [Abstract][Full Text] [Related]
26. Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age. Paolisso G; Buonocore S; Gentile S; Sgambato S; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ Diabetologia; 1990 May; 33(5):272-7. PubMed ID: 2198186 [TBL] [Abstract][Full Text] [Related]
27. Anomalous glucose and insulin responses in patients with insulinoma. Caveats for diagnosis. Dons RF; Hodge J; Ginsberg BH; Brennan MF; Cryer PE; Kourides IA; Gorden P Arch Intern Med; 1985 Oct; 145(10):1861-3. PubMed ID: 2994586 [TBL] [Abstract][Full Text] [Related]
28. [Diagnostic value of parameters of glucose metabolism as screening tests for insulinoma]. Han JF; Zhang F; Bao YQ; Zhou J; Lu W; Lu JX; Jia WP Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1093-6. PubMed ID: 20646424 [TBL] [Abstract][Full Text] [Related]
29. Short fasting test as a reliable and effective tool to diagnose insulinoma. Mikovic N; Mazzilli R; Zamponi V; Russo F; Mancini C; Mori F; Bollanti L; Conti F; Motta C; Monti S; Pugliese G; Faggiano A Endocrine; 2024 Jun; 84(3):1258-1263. PubMed ID: 38451386 [TBL] [Abstract][Full Text] [Related]
30. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects. Keller U; Müller R; Berger W Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637 [TBL] [Abstract][Full Text] [Related]
31. Clinical and diagnostic aspects of cystic insulinoma. Tamagno G; Maffei P; Pasquali C; De Carlo E; Martini C; Mioni R; Crivellaro C; Faggian D; Pedrazzoli S; Sicolo N Scand J Gastroenterol; 2005 Dec; 40(12):1497-501. PubMed ID: 16293564 [TBL] [Abstract][Full Text] [Related]
32. Suppression of endogenous insulin secretion by exogenous insulin in patients with insulinoma. Kim CH; Park JY; Shong YK; Hong SK; Kim GS; Lee KU Clin Endocrinol (Oxf); 2000 Jan; 52(1):87-92. PubMed ID: 10651758 [TBL] [Abstract][Full Text] [Related]
33. Forty-eight-hour fast: the diagnostic test for insulinoma. Hirshberg B; Livi A; Bartlett DL; Libutti SK; Alexander HR; Doppman JL; Skarulis MC; Gorden P J Clin Endocrinol Metab; 2000 Sep; 85(9):3222-6. PubMed ID: 10999812 [TBL] [Abstract][Full Text] [Related]
34. Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma. Davis MR; Shamoon H J Clin Endocrinol Metab; 1991 Apr; 72(4):788-92. PubMed ID: 2005202 [TBL] [Abstract][Full Text] [Related]
35. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism. Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180 [TBL] [Abstract][Full Text] [Related]
36. [Benign insulinoma. Efficacy of preoperative treatment for persistent hyperinsulinemia using a synthetic somatostatin analog]. Esposito V; Esposito D; Lo Iudice G; Rispoli C; Verrillo A; D'Alessandro B Minerva Endocrinol; 1994 Mar; 19(1):33-7. PubMed ID: 8035768 [TBL] [Abstract][Full Text] [Related]
37. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity. Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000 [TBL] [Abstract][Full Text] [Related]
38. Case report: a glucose responsive insulinoma--implication for the diagnosis of insulin secreting tumors. Sjoberg RJ; Kidd GS Am J Med Sci; 1992 Sep; 304(3):164-7. PubMed ID: 1476155 [TBL] [Abstract][Full Text] [Related]
39. Assessment of therapy in gestational diabetes by substrate and hormone responses to a standardized test meal. Nord E; Hanson U; Persson B Diabet Med; 1997 Oct; 14(10):841-8. PubMed ID: 9371476 [TBL] [Abstract][Full Text] [Related]
40. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects. Paolisso G; Sgambato S; Giunta R; Varricchio M; D'Onofrio F Diabete Metab; 1990; 16(1):42-7. PubMed ID: 2332096 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]